Press News | 19.06.2024

Title	Media	Publ. date
Public Health: Antimicrobial resistance will “bring” a new pandemic	Kathimerini	19/06/2024
Collaboration between universities and pharmaceutical companies	Kathimerini	19/06/2024
Introducing new incentives to enhance NHS recruitment on the islands	Kathimerini	18/06/2024
Half of the administrators of the NHS “failed the exams”	Kathimerini	18/06/2024
Health insurance premiums: Increases up to 14% per year	Kathimerini	18/06/2024
Memorandum of cooperation between the government and the pharmaceutical industry	Naftemporiki	19/06/2024
New leadership in SEV	Naftemporiki	19/06/2024

See here the publicity

Web Monitoring Report for the period 18/06 – 19/06

Τίτλος	Μέσο	Ημ. Δημοσίευσης
Olympios Papadimitriou: Fewer new medicines come to Greece compared to other countries	iatropedia.gr	19/06/2024
D. Demos: “The investment program of the pharmaceutical industry is one of the largest in the country”	iatropedia.gr	18/06/2024
“Redefining Value” in pharmaceutical innovation and how to ensure that the Greek patient does not run out of medicines	ieidiseis.gr	19/06/2024
E. Mosialos: The chances of a new pandemic are increasing – Antimicrobial resistance is a serious issue	in.gr	19/06/2024
The electronic prescription is “locked” in the protocols	in.gr	19/06/2024
Restriction on the introduction of new medicines due to mandatory returns – Objectives of the MoH	insider.gr	19/06/2024
Angelis: Separate universal access to pharmaceutical innovation from industry incentives	insider.gr	18/06/2024
Alarmingly high obesity rates in Greece	kathimerini.gr	18/06/2024
Speaking points of the Minister of Health Adonis Georgiadis at the 1st SFEE Summit	moh.gov.gr	18/06/2024
Medicines: Speed race to reduce expenditure by 300 million euros in 2024	moneyreview.gr	19/06/2024
M. Himonas: RRF funding cannot reduce clawback	moneyreview.gr	18/06/2024
Georgiadis: Increased patient access to pharmaceutical innovation requires collective action	moneyreview.gr	18/06/2024
SFEE Summit: Challenges and opportunities for the revision of European pharmaceutical legislation	moneyreview.gr	18/06/2024
Investment of 20 million euros for the evaluation of the services provided by the NHS	moneyreview.gr	18/06/2024
Stefan Oelrich: A courageous effort to protect Research and Technology in medicine is necessary	naftemporiki.gr	19/06/2024
Olympios Papadimitriou: Recognition of innovation is absent	naftemporiki.gr	19/06/2024
Aurelio Arias: Greece lags behind in innovation	naftemporiki.gr	18/06/2024
Z. Rapti: “We want Greece to be an investment destination for pharmaceutical industries”	naftemporiki.gr	18/06/2024
1st SFEE Summit: Roadmap for innovation, digitization and new model of R&D	newsbomb.gr	19/06/2024
Vassilis Katsos: The elections in SEV and the investment in Elliniko	ot.gr	19/06/2024
Innovative medicines: Why only 2 out of 10 are available to Greek patients – The role of the Ministry of Health	ygeiamou.gr	19/06/2024
Adonis Georgiadis: Our priority is to sign a Memorandum of Cooperation with the Pharmaceutical Industry	ygeiamou.gr	18/06/2024
The 3 pillars of the government to support pharmaceutical innovation	ygeiamou.gr	18/06/2024
Greece on the world map of clinical trial investments	ygeiamou.gr	18/06/2024
By the end of the year, we will achieve real-time mapping of human resources in the healthcare sector	ygeiamou.gr	18/06/2024
Digital technology: How it helps make healthcare systems ‘smarter’	ygeiamou.gr	18/06/2024